DMRA(DMRA)
DMRA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | $6M |
| Low | — | — | — | — | $6M |
| High | — | — | — | — | $6M |
| EBITDA Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — |
| Low | — | — | — | — | — |
| High | — | — | — | — | — |
| Net Income Avg | $-2M | $-3M | $-3M | $-3M | $-3M |
| Low | $-3M | $-4M | $-4M | $-3M | $-3M |
| High | $-2M | $-2M | $-3M | $-3M | $-3M |
| EPS Avg | $-1.96 | $-2.11 | $-2.54 | $-2.39 | $-2.55 |
| Low | $-2.19 | $-2.80 | $-3.15 | $-2.39 | $-2.55 |
| High | $-1.54 | $-1.56 | $-1.89 | $-2.39 | $-2.55 |
| Analysts (Rev / EPS) | — / 4 | — / 4 | — / 5 | — / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Net Income Avg | $-16M | $-17M | $-15M | $-16M | $-16M | $-18M |
| Low | $-19M | $-17M | $-15M | $-16M | $-16M | $-18M |
| High | $-13M | $-17M | $-15M | $-16M | $-16M | $-18M |
| EPS Avg | $-0.46 | $-0.49 | $-0.45 | $-0.46 | $-0.47 | $-0.52 |
| Low | $-0.54 | $-0.49 | $-0.45 | $-0.46 | $-0.47 | $-0.52 |
| High | $-0.38 | $-0.49 | $-0.45 | $-0.46 | $-0.47 | $-0.52 |
| Analysts (Rev / EPS) | — / 3 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 |